| NOVAVAX NOVAVAX INC.
2163958 29 Nov 2021 | on 21 Jun 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of infectious diseases, namely, Covid-19, malaria, Ebola, influenza, and respiratory infections; human vaccines; vaccine adjuvants. Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines, and clinical trials and post-market trials related to pharmaceuticals, biologics, and vaccines. | | | NOVAVAX NOVAVAX INC.
2116282 16 Mar 2021 | on 08 Nov 2023 | Class 005 Class 005 Pharmaceutical Products Human vaccines; vaccine adjuvants; pharmaceutical preparations for the treatment of infectious diseases, namely, Covid-19, malaria, Ebola, influenza, and respiratory infections. Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines. | | | NOVAVAX NOVAVAX INC.
(A DELAWARE CORPORATION)
1316026 11 Sep 2006 | on 27 Sep 2011 | Class 041 Class 041 Education and Entertainment Services Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical preparations, vaccines, biologics, related research and development services and other related services. | | | NOVAVAX NANOFLU NOVAVAX INC.
2037741 02 Jul 2020 | on 08 Feb 2023 | Class 005 Class 005 Pharmaceutical Products Human vaccines | | 
